Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gbg Forschungs Gmbh

Clinical trials sponsored by Gbg Forschungs Gmbh, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to stop breast cancer recurrence in High-Risk patients Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New combo therapy aims to slow advanced breast cancer in BRCA patients

Disease control Recruiting now

This study tests whether adding elacestrant to the standard drug olaparib can help people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has a BRCA gene mutation. About 176 participants will be randomly assigned to receive either the combination o…

Phase 2 • Sponsor: GBG Forschungs GmbH • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC